Phase II neoadjuvant clinical trial of carboplatin and eribulin in women with triple negative early-stage breast cancer (NCT01372579)

Virginia G. Kaklamani, Jacqueline S. Jeruss, Elisha Hughes, Kalliopi Siziopikou, Kirsten M. Timms, Alexander Gutin, Victor Abkevich, Zaina Sangale, Cara Solimeno, Krystal L. Brown, Joshua Jones, Anne Renee Hartman, Caitlin Meservey, Borko Jovanovic, Irene Helenowski, Seema A. Khan, Kevin Bethke, Nora Hansen, Regina Uthe, Sara GiordanoSteven Rosen, Kent Hoskins, Jamie Von Roenn, Sarika Jain, Vamsi Parini, William Gradishar

Resultado de la investigación: Articlerevisión exhaustiva

54 Citas (Scopus)

Huella

Profundice en los temas de investigación de 'Phase II neoadjuvant clinical trial of carboplatin and eribulin in women with triple negative early-stage breast cancer (NCT01372579)'. En conjunto forman una huella única.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Nursing and Health Professions

Neuroscience

Biochemistry, Genetics and Molecular Biology